Beta Bionics
BBNX
102 hedge funds and large institutions have $508M invested in Beta Bionics in 2025 Q1 according to their latest regulatory filings, with 102 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
96.2% more ownership
Funds ownership: 0% → 96.2% (+96%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$91.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$72.7M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$63.3M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$62.1M |
| 5 |
RI
RTW Investments
New York
|
+$61.5M |
Top Sellers
BBNX Hedge Fund Activity: Q1 2025 in Review
102 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q1 2025, worth a combined $508M.
Buyers outnumbered sellers: 102 funds opened new BBNX positions and 0 closed out — a net gain of 102 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Eventide Asset Management, opening a new position worth an estimated $91.9M.
- 102 institutional investors held Beta Bionics (BBNX) as of Q1 2025, up from 0 in Q4 2024.
- Funds reported $508M of Beta Bionics stock for Q1 2025.
- 102 funds opened new Beta Bionics positions in Q1 2025 and 0 closed out, a net change of +102 holders.
- The largest Beta Bionics buyer in Q1 2025 was Eventide Asset Management, an estimated $91.9M added.
Based on aggregated 13F filings for Q1 2025.